StarTalk Radio
373 - Ep. 363 - New targets at AACR, biopharma deals, Kurma fund
00:00
00:00
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Episodes
373-
Ep. 363 - New targets at AACR, biopharma deals, Kurma fund
Listened
372-
Ep. 362 - AACR: Data and de-risking
Listened
371-
Ep. 361 - Kelonia, Kailera, pyschedelics and T cell engagers
Listened
370-
Ep. 360 - FDA’s FIH plans. Plus: billion-dollar deals, funds
Listened
369-
